Table 6 HbA1c pattern, N = 47 (patients without insulin)
From: Dipeptidyl Peptidase-4 inhibitors use in type II diabetic patients in a tertiary hospital
HbA1c | Pre DPP-4i use n (%) | Post DPP-4i use n (%) |
|---|---|---|
< 6.5% | 5 (10.6)) | 14 (29.8) |
6.5–9.9% | 37 (78.8) | 32 (68.1) |
≥10% | 5 (10.6) | 1 (2.1) |